CN Patent

CN121399258A — 调控AGT表达的dsRNA分子

Assigned to Darui Biomedical Technology Shanghai Co ltd · Expires 2026-01-23 · 0y expired

What this patent protects

提供了用于抑制细胞中血管紧张素原(AGT)的表达的双链RNA，以及包含其编码核苷酸的载体和细胞、以及利用该dsRNA、载体或细胞治疗受试者中与AGT表达介导或相关的疾病或症状的方法。

USPTO Abstract

提供了用于抑制细胞中血管紧张素原(AGT)的表达的双链RNA，以及包含其编码核苷酸的载体和细胞、以及利用该dsRNA、载体或细胞治疗受试者中与AGT表达介导或相关的疾病或症状的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN121399258A
Jurisdiction
CN
Classification
—
Expires
2026-01-23
Drug substance claim
No
Drug product claim
No
Assignee
Darui Biomedical Technology Shanghai Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.